NAD+/Carnitine Amino Blend
NAD+ / L-Carnitine blend
NAD+/Carnitine Amino Blend (NAD+ / L-Carnitine blend) is a blends & other research compound. Combines NAD+ (mitochondrial energy/repair) with carnitine (fatty-acid transport) for an energy + fat-metabolism stack.
NAD+/Carnitine Amino Blend quick facts
| Reported research dose | 50-100 units |
| Route | Subq |
| Frequency | 1x Daily Pre Exercise · Daily or On Workout Days |
| Half-life | Varies by component |
| Forms | Injectable |
| Evidence level | Anecdotal (blend) |
Pre-exercise energy and fat-use combo. Go slow on the NAD+ portion.
How NAD+/Carnitine Amino Blend works
Combines NAD+ (mitochondrial energy/repair) with carnitine (fatty-acid transport) for an energy + fat-metabolism stack.
Proposed benefits
A combination formula — proposed benefits reflect the sum of its individual components.
✅ Clinically validated
- No trial of the blend. Its components have separate human literature — NAD+ precursors have small trials, and L-carnitine has a substantial one, including work showing benefit only where carnitine status is genuinely low.
📊 Correlative data
- Used for energy and metabolic support. As with every blend, the reported effect is hard to attribute to any one component.
🧪 Theoretical / extrapolated
- Two arms of the same pathway: NAD+ is the cofactor mitochondria need to oxidise fuel, and carnitine is the shuttle that carries long-chain fatty acids into them.
- Combining them is mechanistically coherent — supplying fuel transport without the cofactor to burn it, or the reverse, is the argument for a blend. The honest caveat is that neither is usually the limiting factor in someone healthy and well fed.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
NAD+/Carnitine Amino Blend — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- A lipotropic / metabolic-cofactor blend — B-vitamins, methyl donors and carnitine in varying combinations.
- *the metabolic-cofactor arm:* These act on mitochondrial function, NAD+ availability, sirtuin signalling or cellular clearance. The honest prediction is that acute harm is unlikely and the interesting risks are theoretical and long-range — which is a different shape of risk, not an absence of one.
- *the metabolic-cofactor arm:* Growth and clearance signals cut both ways. Anything that improves the efficiency of cell survival is also improving it for cells you would rather not keep. Anything that pushes clearance hard is doing so indiscriminately.
- *the metabolic-cofactor arm:* The near-term, practical ones: NAD+ precursors and infusions commonly cause flushing and a strong sensation if pushed fast, and several compounds in this class are stimulating enough to disrupt sleep.
- The methyl-donor arm is the one to know about. If you carry an MTHFR variant, or already supplement methylfolate and B12, this adds to that pool rather than starting it — and homocysteine is the marker that reads the result.
- The risk that belongs to the blend rather than any component: double-dosing. If you already run any of the peptides above separately, adding this blend means two doses of it — and almost nobody counts a blend's arms against what is already in their protocol. Read the composition against your current stack before the first injection.
What has actually been reported
- *the metabolic-cofactor arm:* Generally well tolerated at studied doses. NAD+ infusion discomfort is rate-dependent and resolves by slowing down.
- *the metabolic-cofactor arm:* The human evidence is mostly short trials with surrogate endpoints — a marker moved, not a life changed. That is worth knowing before you build a decade-long habit on it.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- *the metabolic-cofactor arm:* Slow the infusion rate. Almost all NAD+ discomfort is rate, not dose. There is no prize for finishing quickly.
- *the metabolic-cofactor arm:* Dose earlier in the day. Several of these are subtly stimulating, and sleep is where most of the repair you are paying for happens.
- *the metabolic-cofactor arm:* Pick an endpoint you can actually measure, and take the baseline before you start. This is the class most prone to spending years on something with no way of knowing whether it did anything.
- *the metabolic-cofactor arm:* Fix the basics first. Sleep, training and bloodwork move the same markers further than anything on this list, and they are free. A longevity compound stacked on four hours of sleep is a rounding error.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- *the metabolic-cofactor arm:* There is no NAD+ assay worth ordering clinically. Judge this class on downstream markers — inflammatory markers, lipids, fasting glucose, and whatever your baseline panel showed as out of range.
Don't run this if
- *the metabolic-cofactor arm:* Active malignancy, for the survival-signalling reasoning above.
- *the metabolic-cofactor arm:* Pregnancy — uncharacterised.
The honest unknown
- *the metabolic-cofactor arm:* Whether any of it extends healthspan in humans. Every honest person in this field is running on mechanism and animal data, and this catalogue should say so rather than imply otherwise.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get NAD+/Carnitine Amino Blend
See vetted vendors for NAD+/Carnitine Amino Blend →NAD+/Carnitine Amino Blend — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What NAD+/Carnitine Amino Blend moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- hs-CRP (High-Sensitivity C-Reactive Protein) — ↓ expected to fall
From the the NAD+/carnitine arm arm. Where these work, systemic inflammation is the plausible readout.
What to do: hs-CRP is cheap and moves. Baseline and 12 weeks. - HbA1c (Hemoglobin A1c) — ↓ expected to fall
From the the NAD+/carnitine arm arm. Improved mitochondrial and metabolic function should show here if the effect is real at all.
What to do: The honest use of these markers is as a falsification test: if nothing moves in 12 weeks, the compound is not doing much for you. - Comprehensive Metabolic Panel (CMP) — ◆ worth watching
From the the NAD+/carnitine arm arm. Liver and kidney function — the standard baseline for anything run long term.
What to do: Twice a year is enough on a stable protocol.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for NAD+/Carnitine Amino Blend — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →A lipotropic / metabolic-cofactor blend — B-vitamins, methyl donors and carnitine in various combinations. The methyl-donor arm is the one worth knowing about: if you carry an MTHFR variant or are already supplementing methylfolate and B12, you are adding to that pool rather than starting it, and homocysteine is the marker that reads the result.
- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Coach Cam's personal notes
Get the complete breakdown for NAD+/Carnitine Amino Blend — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside NAD+/Carnitine Amino Blend
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | Inflammation, which is what most NAD claims route through |
| HbA1c (Hemoglobin A1c) | Metabolic health, the other half |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 102 markers A–Z
NAD+/Carnitine Amino Blend — frequently asked questions
What is NAD+/Carnitine Amino Blend?
NAD+/Carnitine Amino Blend (NAD+ / L-Carnitine blend) is a blends & other research compound. Combines NAD+ (mitochondrial energy/repair) with carnitine (fatty-acid transport) for an energy + fat-metabolism stack.
Is the full NAD+/Carnitine Amino Blend protocol on this page?
The reported research dose is on this page, along with how NAD+/Carnitine Amino Blend works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside the Academy.
What is the half-life of NAD+/Carnitine Amino Blend?
NAD+/Carnitine Amino Blend has an approximate half-life of Varies by component, which is part of what determines how often it's dosed.
What's the evidence behind NAD+/Carnitine Amino Blend?
Current evidence level: Anecdotal (blend). NAD+/Carnitine Amino Blend is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact NAD+/Carnitine Amino Blend protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What NAD+/Carnitine Amino Blend is used for
NAD+/Carnitine Amino Blend appears under 1 goal in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.